As there were no SAMR approval, and didn't seem being promoted by Daigouers, I thought revenue for last half year would be $110m. Giving low stock figures and stock write-off, the results are actually not bad.
For BAL to re-gain credibility, SAMR approval, is the most important to crack, if they received it, then it would be a very good medium/long term bet, imo.
In today's announcement, site audit and doubling marketing activities in China in second half of 2019, are positive signs. SAMR approvals have not released since last October.
BAL Price at posting:
$8.09 Sentiment: Buy Disclosure: Held